J.P. Morgan Private Wealth Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,354	Closed	-$349K	–	1729
2023 Q2	$349K	Sell	19,354 -407	-2%	-$7.33K	﹤0.01%	1177
2023 Q1	$317K	Buy	19,761 +545	+3%	+$8.75K	﹤0.01%	1658
2022 Q4	$352K	Buy	+19,216	New	+$352K	﹤0.01%	1602